Determinants of survival in patients receiving dialysis in Libya

Hemodialysis International

Volumn 17, Issue 2, 2013, Pages 249-255

  Alashek, Wiam A ^a   Mcintyre, Christopher W ^a,b   Taal, Maarten W ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Dialysis; Libya; Mortality; Survival

Indexed keywords

UREA;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; DEATH; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; LIBYAN ARAB JAMAHIRIYA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; ONSET AGE; PROSPECTIVE STUDY; SOCIAL STATUS; SURVIVAL;

ADULT; COHORT STUDIES; FEMALE; HUMANS; LIBYA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84875654353     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00728.x     Document Type: Article

References (24)

1. Pisoni RL, Bragg-Gresham JL, Fuller DS, etal. Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices. Am J Kidney Dis. 2011; 57:266-275.
2. Locatelli F, Marcelli D, Conte F. Dialysis patient outcomes in Europe vs the USA. Why do Europeans live longer? Nephrol Dial Transplant. 1997; 12:1816-1819.
3. Friedman EA. International comparisons of survival on dialysis: Are they reliable? Hemodial Int. 2003; 7:59-66.
4. Jaar BG, Coresh J, Plantinga LC, etal. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005; 143:174-183.
5. Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int. 2011; 80:970-977.
6. Wong JS, Port FK, Hulbert-Shearon TE, etal. Survival advantage in Asian American end-stage renal disease patients. Kidney Int. 1999; 55:2515-2523.
7. Pei YP, Greenwood CM, Chery AL, Wu GG. Racial differences in survival of patients on dialysis. Kidney Int. 2000; 58:1293-1299.
8. Goldstein M, Yassa T, Dacouris N, McFarlane P. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis. 2004; 44:706-714.
9. Avram MM, Bonomini LV, Sreedhara R, Mittman N. Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am J Kidney Dis. 1996; 28:910-917.
10. Port FK, Pisoni RL, Bommer J, etal. Improving outcomes for dialysis patients in the international Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2006; 1:246-255.
11. Al Wakeel JS, Mitwalli AH, Al Mohaya S, etal. Morbidity and mortality in ESRD patients on dialysis. Saudi J Kidney Dis Transpl. 2002; 13:473-477.
12. Batieha A, Abdallah S, Maghaireh M, etal. Epidemiology and cost of haemodialysis in Jordan. East Mediterr Health J. 2007; 13:654-663.
13. Afifi A, Karim MA. Renal replacement therapy in Egypt: First annual report of the Egyptian Society of Nephrology, 1996. East Mediterr Health J. 1999; 5:1023-1029.
14. Saeed B, Derani R, Hajibrahim M, etal. Organ failure in Syria: Initiating a national deceased donation program. Saudi J Kidney Dis Transpl. 2007; 18:270-276.
15. Buargub MA. 5-year mortality in hemodialysis patients: A single center study in Tripoli. Saudi J Kidney Dis Transpl. 2008; 19:268-273.
16. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990; 15:451-457.
17. Stel VS, Kramer A, Zoccali C, Jager KJ. The 2007 ERA-EDTA Registry Annual Report-a Precis. NDT Plus. 2009; 2:514-521.
18. Castledine C, Steenkamp R, Feest T, Tomson C. The Thirteenth Annual Report- Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2009: National and centre-specific analyses. Bristol UK, 2010.
19. Odaka M. Mortality in chronic dialysis patients in Japan. Am J Kidney Dis. 1990; 15:410-413.
20. Shinzato T, Nakai S, Akiba T, etal. Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996. Kidney Int. 1999; 55:700-712.
21. Iseki K, Shinzato T, Nagura Y, Akiba T. Factors influencing long-term survival in patients on chronic dialysis. Clin Exp Nephrol. 2004; 8:89-97.
22. Shigidi MM, Ramachandiran G, Rashed AH, Fituri OM. Demographic data and hemodialysis population dynamics in Qatar: A five year survey. Saudi J Kidney Dis Transpl. 2009; 20:493-500.
23. al-Muhanna FA, Saeed I, al-Muelo S, Larbi E, Rubaish A. Disease profile, complications and outcome in patients on maintenance haemodialysis at King Faisal University Hospital, Saudi Arabia. East Afr Med J. 1999; 76:664-667.
24. Alashek WA, McIntyre CW, Taal MW. Provision and quality of dialysis services in Libya. Hemodial Int. 2011; 15:444-452.